Abstract:In the malignant progression of tumors, there is deposition and cross-linking of collagen, as well as an increase in hyaluronic acid content, which can lead to an increase in extracellular matrix stiffness. Recent research evidence have shown that the extracellular matrix plays an important role in angiogenesis, cell proliferation, migration, immunosuppression, apoptosis, metabolism, and resistance to chemotherapeutic by the alterations toward both secretion and degradation. The clinical importance of tumor-associated macrophage is increasingly recognized, and macrophage polarization plays a central role in a series of tumor immune processes through internal signal cascade, thus regulating tumor progression. Immunotherapy has gradually become a reliable potential treatment strategy for conventional chemotherapy resistance and advanced cancer patients, but the presence of immune exclusion has become a major obstacle to treatment effectiveness, and the reasons for their resistance to these approaches remain uncertain. Currently, there is a lack of exact mechanism on the regulation of extracellular matrix stiffness and tumor-associated macrophage polarization on immune exclusion. An in-depth understanding of the relationship between extracellular matrix stiffness, tumor-associated macrophage polarization, and immune exclusion will help reveal new therapeutic targets and guide the development of clinical treatment methods for advanced cancer patients. This review summarized the different pathways and potential molecular mechanisms of extracellular matrix stiffness and tumor-associated macrophage polarization involved in immune exclusion and provided available strategies to address immune exclusion.

Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments

Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer.

Extracellular matrix remodeling in the tumor immunity

The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?

Targeting Extracellular Matrix Interaction in Gastrointestinal Cancer: Immune Modulation, Metabolic Reprogramming, and Therapeutic Strategies

Extracellular matrix and its therapeutic potential for cancer treatment

Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy

The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis

The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets

The Matrix Reloaded—The Role of the Extracellular Matrix in Cancer

The Role of Extracellular Matrix Remodeling in Skin Tumor Progression and Therapeutic Resistance

Inflammation, Extracellular Matrix Remodeling, and Proteostasis in Tumor Microenvironment

Insights into the mechanisms, regulation, and therapeutic implications of extracellular matrix stiffness in cancer

Biomaterials to regulate tumor extracellular matrix in immunotherapy

Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion

The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in PDAC

The extracellular matrix in solid tumor immunotherapy

The Functional Role of Extracellular Matrix Proteins in Cancer

Understanding the matrix: collagen modifications in tumors and their implications for immunotherapy

Extracellular Matrix and Cancer-associated Fibroblasts

Targeting extracellular matrix through phytochemicals: a promising approach of multi-step actions on the treatment and prevention of cancer